Progressive's industry-leading underwriting margin of 88.7% and solid 6% policy expansion remain formidable, but moderating premium growth and competitive pricing normalize earnings toward $18.94 in 2027. At 10.8 times trailing earnings and 3.6 times book value, shares fairly discount steady compounding. We initiate coverage with a Hold rating and a $220.00 price target.
Key points
- $18.94 is our 2027 diluted earnings estimate, reflecting 6% earned premium expansion alongside disciplined combined ratio normalization to 90.0%.
- 88.7% third-quarter combined ratio confirms industry-leading underwriting margins, but year-over-year net premium written growth cooled to 4%.
- 3.59 times current book value leaves shares balanced against normalized earnings, warranting an initiation at Hold.
The call
At $213.46, the stock prices in sustained peak profitability. The current valuation requires Progressive to generate approximately $18.50 to $19.00 in EPS while keeping its combined ratio near 89%. That leaves minimal cushion for returning price competition, rising advertising costs, or catastrophe normalization across expanded personal lines.
Quarterly Combined Ratio and Normalization Trajectory- Reported Combined Ratio (%)
- Desk Forecast Combined Ratio (%)
Source: Progressive Corporation SEC filings and quarterly releases; desk estimates.
We believe underwriting margins will gently normalize rather than crack. Progressive's best-in-class telematics segmentation and claims efficiency defend an 88% to 90% combined ratio, far superior to its 96% operating ceiling. With net investment yields holding near 4.3% across a $99 billion portfolio, earnings compound steadily, supporting a fair 12-month value.
2027E Implied Share Price Across Underwriting Margin OutcomesSource: Desk scenario model based on 2027E earned premiums of $92.5B and $102B portfolio at 4.3% yield.
Valuation
| Valuation metric | Estimate |
|---|
| 2027E Net premiums earned | $92.5B |
| 2027E Combined ratio | 90.0% |
| 2027E Underwriting profit | $9.25B |
| 2027E Net investment & other income (pretax) | $4.56B |
| 2027E Diluted EPS | $18.94 |
| Target P/E multiple | 11.6× |
| 12-month price target | $220.00 |
Our $220.00 target applies an 11.6 times multiple to 2027 earnings, consistent with historical mid-cycle insurance valuations. On projected year-end 2027 equity of $78.40 per share, the target represents 2.8 times book value. Asymmetric upside is limited by moderating premium growth, making Hold the disciplined stance.
Risks
- Accelerating competitor appetite from GEICO and Allstate triggers aggressive rate discounting, compressing vehicle retention and policy life expectancy.
- Inflation in vehicle replacement parts and bodily injury severity outpaces pricing model updates, lifting the loss ratio.
- Severe weather catastrophes breach primary retention thresholds in newly reopened property markets, eroding non-vehicle underwriting profits.
What would change my mind
We would upgrade to Buy if policy growth reaccelerates into double digits while the combined ratio remains suppressed below 87%, demonstrating market share gains without margin concession.